ResearchMulticenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States
ResearchThe Safety and Effectiveness of Early Anti-tumor-necrosis-factor Therapy for Penetrating Crohn's Disease Complications in Children
ResearchAminosalicylate use Increases Corticosteroid Exposure and Decreases Biologic Durability in Pediatric Crohn's Disease
ResearchNational perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
ResearchMultiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD)
ResearchHave we hit the JAK-pot? Success of selective JAK 1 inhibitor following failure of pan-JAK inhibitor in refractory pediatric ulcerative colitis
ResearchA narrative review of the ileal pouch in pediatric inflammatory bowel disease and familial adenomatous polyposis
ResearchMulticenter study of continuing ustekinumab after intravenous induction reactions in pediatric Crohn's disease
ResearchAcquired pelvic splenosis in a pediatric patient with inflammatory bowel disease: A rare case report
ResearchReshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paper
ResearchSevere allergic reaction to ustekinumab reinitiation in a pediatric patient with Crohn's disease: A case report